Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Blanck

Showing results (21-30 of 144) with videos related to

Pageof 15
Sort By:
Cancer Genetics and Cytogenetics|May 19, 2009
Genes that contribute to cancer fusion genes are large and evolutionarily conservedSwetha Narsing, Zhihong Jelsovsky, Alfred Mbah, et al.
Cancer Genomics & Proteomics|November 7, 2015
A Novel Approach to Evaluating Cancer Driver Gene Mutation Densities: Cytoskeleton-related Gene CandidatesTimothy J Fawcett, Michele L Parry, George Blanck
Biomedical Reports|August 15, 2017
Protected cytoskeletal-related proteins: Towards a resolution of contradictions regarding the role of the cytoskeleton in cancerDaniel T Segarra, John M Yavorski, George Blanck
Journal of Cancer Research and Clinical Oncology|March 17, 2009
Substantially reduced expression of PIAS1 is associated with colon cancer developmentDomenico Coppola, Vevek Parikh, David Boulware, et al.
International Journal of Laboratory Hematology|May 9, 2022
Exploiting adaptive immune receptor recombination read recoveries from exome files to identify subsets of ALL and to establish TCR features that correlate with better outcomesEtienne C Gozlan, Boris I Chobrutskiy, George Blanck
Gene|March 5, 2017
Stratifying melanoma and breast cancer TCGA datasets on the basis of the CNV of transcription factor binding sites common to proliferation- and apoptosis-effector genesJames A Mauro, John M Yavorski, George Blanck
Cancer Cell International|April 10, 2019
An age-based, RNA expression paradigm for survival biomarker identification for pediatric neuroblastoma and acute lymphoblastic leukemiaAndrea Diviney, Boris I Chobrutskiy, Saif Zaman, et al.
Anticancer Research|May 27, 2026
A Landscape of Immunogenomics Assessments for Endemic Burkitt Lymphoma: Relevance to OutcomesTaha I Huda, Rahul Jain, Tushar Singh, et al.
Oncology Reports|December 12, 2018
MAPT (Tau) expression is a biomarker for an increased rate of survival for low‑grade gliomaSaif Zaman, Boris I Chobrutskiy, Dhiraj Sikaria, et al.
Cell Cycle (Georgetown, Tex.)|May 7, 2015
Tumor suppressor genes are larger than apoptosis-effector genes and have more regions of active chromatin: Connection to a stochastic paradigm for sequential gene expression programsMarlene Garcia, James A Mauro, Michael Ramsamooj, et al.
Pageof 15

Showing results (21-30 of 144) with videos related to

Sort By:
Pageof 15
Cancer Genetics and Cytogenetics|May 19, 2009
Genes that contribute to cancer fusion genes are large and evolutionarily conservedSwetha Narsing, Zhihong Jelsovsky, Alfred Mbah, et al.
Cancer Genomics & Proteomics|November 7, 2015
A Novel Approach to Evaluating Cancer Driver Gene Mutation Densities: Cytoskeleton-related Gene CandidatesTimothy J Fawcett, Michele L Parry, George Blanck
Biomedical Reports|August 15, 2017
Protected cytoskeletal-related proteins: Towards a resolution of contradictions regarding the role of the cytoskeleton in cancerDaniel T Segarra, John M Yavorski, George Blanck
Journal of Cancer Research and Clinical Oncology|March 17, 2009
Substantially reduced expression of PIAS1 is associated with colon cancer developmentDomenico Coppola, Vevek Parikh, David Boulware, et al.
International Journal of Laboratory Hematology|May 9, 2022
Exploiting adaptive immune receptor recombination read recoveries from exome files to identify subsets of ALL and to establish TCR features that correlate with better outcomesEtienne C Gozlan, Boris I Chobrutskiy, George Blanck
Gene|March 5, 2017
Stratifying melanoma and breast cancer TCGA datasets on the basis of the CNV of transcription factor binding sites common to proliferation- and apoptosis-effector genesJames A Mauro, John M Yavorski, George Blanck
Cancer Cell International|April 10, 2019
An age-based, RNA expression paradigm for survival biomarker identification for pediatric neuroblastoma and acute lymphoblastic leukemiaAndrea Diviney, Boris I Chobrutskiy, Saif Zaman, et al.
Anticancer Research|May 27, 2026
A Landscape of Immunogenomics Assessments for Endemic Burkitt Lymphoma: Relevance to OutcomesTaha I Huda, Rahul Jain, Tushar Singh, et al.
Oncology Reports|December 12, 2018
MAPT (Tau) expression is a biomarker for an increased rate of survival for low‑grade gliomaSaif Zaman, Boris I Chobrutskiy, Dhiraj Sikaria, et al.
Cell Cycle (Georgetown, Tex.)|May 7, 2015
Tumor suppressor genes are larger than apoptosis-effector genes and have more regions of active chromatin: Connection to a stochastic paradigm for sequential gene expression programsMarlene Garcia, James A Mauro, Michael Ramsamooj, et al.
Pageof 15